The absence of PCI and primary PCI centres, particularly in tier II and tier III cities, and poor access to healthcare services in rural parts of India are anticipated to restrain market expansion.
Also, it is anticipated that ischemic adverse events linked to coronary stenting, such as ischemia-driven target lesion revascularization and stent thrombosis, may restrain market expansion.
Moreover, widespread use of stents in the treatment of cardiovascular blockage is anticipated to support India Coronary Stents Market expansion. Because to its non-invasive nature, which provides patients with less pain and a faster recovery period than more invasive bypass procedures, stents are often recommended.
Read More:
https://knackersblogger.blogspot.com/2023/03/india-coronary-stents-market-size-share.html
Comments
0 comment